The Global Burden of Alzheimer’s disease

• No treatment is available to slow or stop the deterioration of brain cells in Alzheimer’s patients.
• The FDA has approved 5 drugs that temporarily slow worsening of symptoms for 6-12 months.
• These compounds work for about 50% of patients.
• Despite extremely poor results, these 5 drugs generate over $6 billion annually.
• 20 million people worldwide are currently affected by Alzheimer’s disease.
• The global incidence of dementia is estimated to reach 35.6 million by 2010.
• The global economic cost of dementia is estimated to be in excess of $315 billion.

U.S. Alzheimer’s Incidence

• Over 5.3 million American’s have Alzheimer’s disease
• A new case is diagnosed every 70 seconds, a rate that will more than double in 20 years.
• One in eight American’s over the age of 65 (13%) have Alzheimer’s disease.

U.S. Economic Costs of Alzheimer’s disease

• Alzheimer’s disease costs the US economy $148 billion annually.
• American’s aged 65 and older have triple the healthcare costs than those without Alzheimer’s disease.

* Source: Alzheimer’s Association™ and Alzheimer’s Disease International